Nov. 12, 2021
At vero eos et accusamus et iusto odio dignissimos ducimus qui blanditiis praesentium voluptatum deleniti atque corrupti quos dolores et quas.
Patients with Parkinson disease and healthcare professionals caring for them have expressed concerns about the COVID-19 vaccine's efficacy and safety in the specific context of Parkinson disease and its symptomatic treatment. In a commentary just published in the Journal of Parkinson's Disease, a set of experts addresses these concerns from an evidence-based perspective. Their conclusion is that COVID-19 vaccination with approved vaccines should be recommended to persons with Parkinson disease, unless there is a specific contraindication.
"The arrival of these vaccines has created hope for people with Parkinson disease, as this can help to mitigate their risk of becoming infected with the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which can lead to serious, life-threatening disease, at least among those with more advanced Parkinson disease," explains lead author Bastiaan R Bloem MD PhD, Radboud University Nijmegen Medical Center; Donders Institute for Brain, Cognition and Behavior; Department of Neurology, Nijmegen, the Netherlands, and co-Editor-in-Chief of the Journal of Parkinson's Disease.
Based on the authors' interpretation of the scientific literature, the unfolding experience with widespread vaccination in the population at large, and input from the International Parkinson and Movement Disorder Society Scientific Issues Committee (IPMDS-SIC), the take home messages with respect to COVID-19 vaccination for persons with Parkinson disease are:
The authors strongly encourage visiting the website of the International Parkinson and Movement Disorder Society where recommendations will be updated as new data are published based on further experience, clinical trials and real-life clinical practice: https://www.movementdisorders.org/MDS-Files1/COVID-19vaccination01042021.pdf (for medical professionals) and https://www.movementdisorders.org/COVID-19-Pandemic-MDS/MDS-COVID-19-Vaccine-Statement-for-Patients.htm (for persons with Parkinson disease).
"Taking all current evidence into consideration, perhaps this is the light at the end of the tunnel. We encourage our community of movement disorder specialists to recommend COVID-19 vaccination with approved vaccines to their patients with Parkinson disease or their responsible caregivers, unless there is a specific contraindication," states Prof. Bloem. "Finally, even after vaccination, it is important that persons with Parkinson disease continue complying with the public health guidelines to reduce exposure and transmission of COVID-19 as recommended by the World Health Organization and the Centers for Disease Control and Prevention."
Source: News Release
February 3, 2021